topiramate
Generic: topiramate
Labeler: pd-rx pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
topiramate
Generic Name
topiramate
Labeler
pd-rx pharmaceuticals, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
topiramate 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72789-004
Product ID
72789-004_37663bc9-c517-c973-e063-6394a90aed91
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090278
Listing Expiration
2026-12-31
Marketing Start
2014-12-15
Pharmacologic Class
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72789004
Hyphenated Format
72789-004
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
topiramate (source: ndc)
Generic Name
topiramate (source: ndc)
Application Number
ANDA090278 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-004-21)
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-004-30)
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-004-60)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "37663bc9-c517-c973-e063-6394a90aed91", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0372789004303"], "unii": ["0H73WJJ391"], "rxcui": ["199889"], "spl_set_id": ["e846124d-e9e6-42c7-83f1-5df170d3f70b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-004-21)", "package_ndc": "72789-004-21", "marketing_start_date": "20190820"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-004-30)", "package_ndc": "72789-004-30", "marketing_start_date": "20190820"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-004-60)", "package_ndc": "72789-004-60", "marketing_start_date": "20200317"}], "brand_name": "Topiramate", "product_id": "72789-004_37663bc9-c517-c973-e063-6394a90aed91", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72789-004", "generic_name": "Topiramate", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA090278", "marketing_category": "ANDA", "marketing_start_date": "20141215", "listing_expiration_date": "20261231"}